The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTAU.L Regulatory News (TAU)

  • There is currently no data for TAU

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Investment Update

22 Sep 2016 07:00

RNS Number : 5036K
Tau Capital PLC
22 September 2016
 

TAU CAPITAL PLC

(the "Company" or "Tau")

 

 

Investment Update

 

Following the announcement made on 30 June 2016 (release of the Annual Financial Statements for the year ended 31 December 2015), the Company is providing an update on the sale of Stopharm LLP ("Stopharm").

 

On 29 September 2014 the Company announced that it had received an offer of US$ 7 million from Capital Gate Holdings LLP ("Capitalgate") for its holding in Stopharm.. This was subject to certain conditions including receiving approval from the Anti-Monopoly Commission of Kazakhstan.

 

On 30 June 2016 the Company announced that at least one other expression of interest had been received from a third party in acquiring the entire interest in Stopharm.

 

The Board is of the opinion that the interests of shareholders are best served by actively pursuing the sale of the Company's interest in Stopharm along the existing avenues set out in earlier announcements but at the same time exploring new avenues for a potential sale both directly and through other intermediaries. The Board also believes that, although achieving the best possible value from a sale will inevitably take longer to achieve under the current market circumstances referred to above, there is no alternative which serves the interests of shareholders better. There remains uncertainty both as to the timing and the proceeds from a sale. The downturn in the Kazakhstan economy and the devaluation of the Tenge have had a negative impact on disposing of the Company's interest within the time horizon originally envisioned - there is no expectation of an imminent transaction or any certainty that either of the transactions will complete.

 

As to Stopharm itself the financial results of the company for the year ending 31 December 2015 showed that they had returned to profitability although the material devaluation of the Tenge in 2015 had a negative effect on their results. Since 31 December 2015 the Tenge has showed signs of stabilising - the current exchange rate of the Kazakhstan Tenge to the US Dollar is 340.3 to 1.

 

 

 

Further information, please contact:

 

 

FIM Capital Limited

Philip Scales

Tel: +44 (0) 1624 681250

Numis Securities Ltd

Nominated Adviser: Hugh Jonathan

Corporate Broking: Nathan Brown

Tel: +44 (0) 20 7260 1000

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
UPDAKDDBCBKDCCB
Date   Source Headline
23rd Oct 20193:09 pmRNSStatement re (cancellation of trading on AIM)
8th Oct 20193:00 pmRNSStatement re potential cancellation of trading
2nd Sep 20197:00 amRNSInterim Results
27th Jun 20197:00 amRNSFinal Results
30th Apr 20195:00 pmRNSTotal Voting Rights
23rd Apr 20197:30 amRNSSuspension - Tau Capital Plc
23rd Apr 20197:00 amRNSStatement re suspension of shares
16th Apr 20199:09 amRNSHolding(s) in Company
12th Apr 20193:42 pmRNSHolding(s) in Company
12th Apr 201911:38 amRNSDirectorate Changes
12th Apr 20199:58 amRNSHolding(s) in Company
12th Apr 20199:15 amRNSHolding(s) in Company
8th Apr 201911:51 amRNSResult of Extraordinary General Meeting
19th Mar 20197:00 amRNSREPLACEMENT: Posting of Circular to Shareholders
18th Mar 20192:25 pmRNSPosting of Circular to Shareholders
15th Mar 201911:30 amRNSDistribution of Cash, Placing and Other Matters
8th Feb 20193:17 pmRNSHolding(s) in Company
7th Feb 20191:48 pmRNSCompany Update
1st Feb 20192:46 pmRNSCompany Update
21st Jan 201911:05 amRNSSecond Price Monitoring Extn
21st Jan 201911:00 amRNSPrice Monitoring Extension
4th Dec 20184:31 pmRNSCompany Update
19th Nov 201812:11 pmRNSResult of AGM
18th Oct 20183:20 pmRNSCompletion of Disposal
11th Oct 20183:32 pmRNSNotice of AGM
4th Oct 201810:49 amRNSResult of EGM
28th Sep 20187:00 amRNSHalf-year Report
19th Sep 20187:30 amRNSRestoration - Tau Capital Plc
18th Sep 20185:30 pmRNSPosting of Accounts and Restoration of Trading
17th Sep 20185:26 pmRNSPosting of Shareholder Circular and Notice of EGM
17th Sep 20187:00 amRNSFinal Results
28th Aug 20187:00 amRNSConditional sale of holding in Stopharm LLC
2nd Jul 20187:30 amRNSSuspension - Tau Capital Plc
29th Jun 20187:00 amRNSUpdate re. suspension of trading
26th Jun 20182:05 pmRNSImpairment of Investment
21st Mar 20182:24 pmRNSHolding(s) in Company
29th Sep 20177:00 amRNSHalf-year Report
31st Jul 201711:41 amRNSResult of AGM
7th Jul 201710:30 amRNSNotice of AGM
30th Jun 20177:00 amRNSFinal Results
1st Jun 20174:25 pmRNSHolding(s) in Company
1st Jun 20174:22 pmRNSHolding(s) in Company
14th Dec 20167:00 amRNSChange of Adviser
30th Sep 20167:00 amRNSHalf-year Report
22nd Sep 20167:00 amRNSInvestment Update
8th Aug 20163:09 pmRNSResult of AGM
1st Jul 20165:10 pmRNSNotice of AGM
30th Jun 20169:57 amRNSFinal Results
30th Sep 20157:00 amRNSHalf Yearly Report
10th Jul 20153:08 pmRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.